Transcatheter Closure of Special Patent Ductus Arteriosus

高伟,周爱卿,余志庆,李奋,钟玉敏
DOI: https://doi.org/10.3969/j.issn.1004-8812.2003.04.009
2003-01-01
Abstract:Objective To assess the effect and methology in occlusion of special patent ductus arteriosus (PDA). Methods Transcatheter closure of special PDA with Amplatzer Duct Occluder and Duct Occluder was performed in 51 patients, of whom 3 had pulmonary stenosis(PS), 3 coarctation of aorta (COA), 2 atrial septal defect (ASD), 3 aortic stenosis (AS), 1 right aortic arch and 1 corrected transposition of the great arteries, and 38 moderate to severe mitral regurgitation (MR). They were all performed with balloon dilation. ASD was treated with other closure devices simultaneously. Results The device was successfully implanted in the 51 patients. The mean minimum diameter of the PDA was (3.0±1.2) mm (ranging from 1.2 to 6.9 mm). The clinical closure rate and the echocardiographic complete closure rate were both 100% at discharge. Device placement was successful and complete occlusion occurred immediately in 2 cases with ASD. Balloon dilation was successful too. The results showed that 35 of 38 (92.1%) cases in PDA with MR got better outcome. At a median follow-up interval of 3.8 years there were no complications. Conclusion It is suggested that PDA occluder devices are safe for the catheter closure of the special PDA.
What problem does this paper attempt to address?